TFC Financial Management
NAMSW icon

TFC Financial Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

TFC Financial Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,181
Closed -$43.3K – 1012
2024
Q3 		$43.3K Sell
6,181
-3,819
-38% -$29.6K 0.01% 265
2024
Q2 		$87.2K Buy
+10,000
New +$93.3K 0.02% 190

Other funds holding NAMSW

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TFC Financial Management's NAMSW Position: Q4 2024 in Review

TFC Financial Management sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q4 2024, closing a stake of 6,181 shares — an estimated $43.3K sold.

TFC Financial Management first reported a position in NAMSW in Q2 2024 and held it in 2 quarters. The position peaked at $87.2K in Q2 2024. 11 funds tracked by Wall St. Rank hold NAMSW as of Q4 2024.

  • TFC Financial Management reported no remaining NewAmsterdam Pharma Warrant position as of Q4 2024 after selling out during the quarter.
  • TFC Financial Management sold 6,181 NewAmsterdam Pharma Warrant shares in Q4 2024, an estimated $43.3K.
  • TFC Financial Management first reported a position in NewAmsterdam Pharma Warrant in Q2 2024 and held it in 2 quarters.
  • TFC Financial Management's NewAmsterdam Pharma Warrant position peaked at $87.2K in Q2 2024.
  • 11 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q4 2024.

Based on TFC Financial Management's 13F filing for Q4 2024, filed 29 Jan 2025.